MedTrace Logo

New Medication Treatment for Stimulant Dependence

NCT00689572 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2021-11-11

Study results available
· View outcomes & findings →

Summary

This study will evaluate the efficacy of ondansetron compared with placebo in the treatment of cocaine dependence.

Conditions

  • Cocaine Dependence

Interventions

DRUG

Ondansetron

4 mg twice a day + Cognitive Behavioral Therapy + Brief Behavioral Enhancement Therapy

DRUG

Placebo

twice a day + Cognitive Behavioral Therapy + Brief Behavioral Enhancement Therapy

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • University of Virginia

    lead OTHER

Principal Investigators

  • Nassima Ait-Daoud Tiouririne, M.D. · University of Virginia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2013-12-31
Completion
2013-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00689572 on ClinicalTrials.gov